Terazosin activates Pgk1 and Hsp90 to promote stress resistance.
Terazosin activates Pgk1 and Hsp90 to promote stress resistance.
复制标题
DOI:
10.1038/nchembio.1657
复制
发表时间:
2015-01
影响因子:
14.8
通讯作者:
Liu, Lei
中科院分区:
文献类型:
--
作者:
Chen, Xinping;Zhao, Chunyue;Li, Xiaolong;Wang, Tao;Li, Yizhou;Cao, Cheng;Ding, Yuehe;Dong, Mengqiu;Finci, Lorenzo;Wang, Jia-huai;Li, Xiaoyu;Liu, Lei
Drugs that can protect against organ damage are urgently needed, especially for diseases such as sepsis and brain stroke. We have discovered that terazosin (TZ), a widely marketed alpha1-adrenergic receptor agonist, alleviated organ damage and improved survival in rodent models of stroke and sepsis. Through combined studies of enzymology and X-ray crystallography, we have discovered that TZ binds to a novel target, phosphoglycerate kinase 1 (Pgk1) and activates its enzymatic activity, probably through 1,3-diamino-6,7-dimethoxyisoquinoline's ability to promote ATP release from Pgk1. Mechanistically, the ATP generated from Pgk1 may enhance the chaperone activity of Hsp90, an ATPase known to associate with Pgk1. Upon activation, Hsp90 promotes multi-stress resistance. Our studies have demonstrated that TZ has a novel protein target, Pgk1, and has revealed its corresponding biological effect. As a clinical drug, TZ may be quickly translated into treatment of devastating diseases including stroke and sepsis.
登录
查看更多内容
DOI:
10.1164/rccm.200702-291oc
发表时间:
2007-10-01
影响因子:
24.7
作者:
Chatterjee, Anuran;Dimitropoulou, Christiana;Catravas, John D.
通讯作者:
Catravas, John D.
影响因子:
4.8
作者:
Lewis, J;Devin, A;Liu, ZG
通讯作者:
Liu, ZG
影响因子:
3.5
作者:
Falsone, SF;Gesslbauer, B;Kungl, AJ
通讯作者:
Kungl, AJ
DOI:
10.1152/ajplung.00350.2007
发表时间:
2008-04-01
影响因子:
4.9
作者:
Chatterjee, Anuran;Snead, Connie;Catravas, John D.
通讯作者:
Catravas, John D.
影响因子:
--
作者:
Ai, Jianzhong;Huang, Huizhe;Zhou, Qin
通讯作者:
Zhou, Qin